JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

Search

T2 Biosystems Inc

Open

0.13

Overview

Share price change

24h

Current

Min

0.13

Max

0.13

Dividends

By Dow Jones

Next Earnings

13 lis 2025

T2 Biosystems Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 lis 2025, 21:44 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 lis 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 lis 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 lis 2025, 23:28 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 lis 2025, 23:24 UTC

Earnings

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

3 lis 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 lis 2025, 23:12 UTC

Earnings

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 lis 2025, 23:06 UTC

Market Talk
Earnings

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 lis 2025, 22:36 UTC

Market Talk
Earnings

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q EPS $1.49 >FNV

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q Rev $487.7M >FNV

3 lis 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 lis 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 lis 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk
Earnings

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

3 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 lis 2025, 21:49 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 lis 2025, 21:40 UTC

Earnings

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 lis 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 lis 2025, 21:19 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 lis 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 lis 2025, 21:11 UTC

Earnings

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 lis 2025, 21:07 UTC

Earnings

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 lis 2025, 21:05 UTC

Earnings

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 lis 2025, 21:05 UTC

Earnings

Palantir Technologies 3Q Net $475.6M >PLTR

Peer Comparison

Price change

T2 Biosystems Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

$

help-icon Live chat